Real-world experience of the 6 weekly schedule (q6w) of pembrolizumab in patients (pts) with metastatic non-small cell lung cancer (mNSCLC)

被引：0
|
作者：
Tariq, Noor-Ul-Ain [1 ]
Anderson, Christian [2 ]
Gartside, Eleanor [1 ]
Wong, Helen [1 ]
Dobson, Lisa [1 ]
Anthonypillai, Marry [1 ]
Griffiths, Richard [1 ]
Pope, Anthony [1 ]
机构：
[1] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[2] Univ Liverpool, Clatterbridge, England
来源：
LUNG CANCER | 2022年 / 165卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
80
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [41] Real-world monitoring of hybrid dosing of pembrolizumab in stage IV non-small cell lung cancer in the Netherlands
    Dronkers, E.
    Van Geffen, E.
    Bekkers, C.
    Sobels, A.
    van Drie-Pierik, R.
    Eldering-Heldens, A.
    Zwaveling, J.
    Eijsink, J.
    Smit, H. J. M.
    Hilarius, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S73 - S73
  • [42] Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre
    Fletcher, J.
    Mullally, W. J.
    Berman, C.
    Ladwa, R.
    Xu, W.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S628 - S629
  • [43] Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study
    Mountzios, Giannis
    Lampaki, Sofia
    Linardou, Helena
    Georgoulias, Vassilis
    Mavroudis, Dimitrios
    Anevlavis, Stavros
    Charpidou, Andriani
    Lykka, Maria
    Spyratos, Dionysis
    Sarris, Evangelos G.
    Somarakis, Alvertos
    Papista, Christina
    Glentis, Alexandros
    Nikolaou, Aristeidis
    Paparepa, Zoe
    Papageorgiou, Foteini
    Syrigos, Konstantinos N.
    FUTURE ONCOLOGY, 2025, 21 (04) : 447 - 462
  • [44] Pembrolizumab in non-small cell lung cancer: our experience
    Rizvi, S. A.
    Reza, S.
    Kabba, T.
    Ajzensztejn, D.
    Dwyer, M.
    Randhawa, R.
    Karina, M.
    LUNG CANCER, 2019, 127 : S83 - S83
  • [45] REAL-WORLD PATTERNS OF BIOMARKER TESTING IN METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Roncadori, A.
    Massa, I
    Balzi, W.
    Danesi, V
    Rengucci, C.
    Gentili, N.
    Crino, L.
    Delmonte, A.
    Altini, M.
    VALUE IN HEALTH, 2022, 25 (01) : S255 - S255
  • [46] REAL-WORLD HEALTHCARE COSTS IN PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER IN ITALY
    Danesi, V
    Massa, I
    Altini, M.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Manunta, S.
    Ejzykowicz, F.
    Delmonte, A.
    VALUE IN HEALTH, 2019, 22 : S451 - S451
  • [47] Treatment patterns and real-world clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
    Moser, S. Sharman
    Apter, L.
    Arunachalam, A.
    Gazit, S.
    Chodick, G.
    Siegelmann-Danieli, N.
    ANNALS OF ONCOLOGY, 2023, 34
  • [48] Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada
    Yusuf, Dimas
    Ko, Jenny J.
    Cho, Hyokeun
    Sheremeto, Corey
    Wang, Ying
    Juergens, Rosalyn A.
    Ellis, Peter Michael
    Billawala, Alkarim
    Kay, Amin
    Kulkarni, Swati
    Elfiki, Tarek A.
    Gupta, Rasna
    Naccarato, Krista
    Pennetti, Alex
    Patel, Devalben
    Smith, Elliot Charles
    Walton, Ryan
    Hurry, Manjusha
    Liu, Geoffrey
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [49] Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancer
    Popat, Sanjay
    Brustugun, Odd Terje
    Cadranel, Jacques
    Felip, Enriqueta
    Garassino, Marina Chiara
    Griesinger, Frank
    Helland, Aslaug
    Hochmair, Maximilian
    Perol, Maurice
    Bent-Ennakhil, Nawal
    Kruhl, Christian
    Novello, Silvia
    LUNG CANCER, 2021, 157 : 9 - 16
  • [50] Real-World Effectiveness of Second-Line Therapies for Metastatic Non-Small Cell Lung Cancer
    Bazhenova, L.
    Cai, B.
    Gentile, D.
    Kari, G.
    Feinberg, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E22 - E22
12345